← Back to Search

Main Group for Human Papillomavirus (SWISH Trial)

N/A
Recruiting
Research Sponsored by Vivent Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this is a single visit study for participants and will collect 300 oral samples at the visit and will analyze samples and will compare participant demographics with hiv disease state in approximately 18 months from the start study
Awards & highlights

SWISH Trial Summary

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

Eligible Conditions
  • Human Papillomavirus
  • HIV/AIDS

SWISH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this is a single visit study for participants analyze samples and participant demographic in approximately 18 months from the start study
This trial's timeline: 3 weeks for screening, Varies for treatment, and this is a single visit study for participants analyze samples and participant demographic in approximately 18 months from the start study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HPV Prevalence in people living with HIV
Secondary outcome measures
Correlation of other factors to oral HPV
Demographics of other factors to oral HPV
Oral lesion prevalence with HPV positive samples

SWISH Trial Design

1Treatment groups
Experimental Treatment
Group I: Main GroupExperimental Treatment1 Intervention
Single group, observational cross-sectional cohort.

Find a Location

Who is running the clinical trial?

Vivent HealthLead Sponsor
1 Previous Clinical Trials
150 Total Patients Enrolled
H. Lee Moffitt Cancer Center and Research InstituteOTHER
542 Previous Clinical Trials
135,192 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV
Cindy Firnhaber 2023. "The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06205511.
All > Denver > Colorado Springs
~71 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top